1. Home
  2. TUSK vs IKT Comparison

TUSK vs IKT Comparison

Compare TUSK & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TUSK
  • IKT
  • Stock Information
  • Founded
  • TUSK 2014
  • IKT 2008
  • Country
  • TUSK United States
  • IKT United States
  • Employees
  • TUSK N/A
  • IKT N/A
  • Industry
  • TUSK Oilfield Services/Equipment
  • IKT Biotechnology: Pharmaceutical Preparations
  • Sector
  • TUSK Energy
  • IKT Health Care
  • Exchange
  • TUSK Nasdaq
  • IKT Nasdaq
  • Market Cap
  • TUSK 142.5M
  • IKT 131.6M
  • IPO Year
  • TUSK 2016
  • IKT 2020
  • Fundamental
  • Price
  • TUSK $2.83
  • IKT $1.72
  • Analyst Decision
  • TUSK
  • IKT Buy
  • Analyst Count
  • TUSK 0
  • IKT 2
  • Target Price
  • TUSK N/A
  • IKT $8.00
  • AVG Volume (30 Days)
  • TUSK 126.9K
  • IKT 504.3K
  • Earning Date
  • TUSK 08-08-2025
  • IKT 08-13-2025
  • Dividend Yield
  • TUSK N/A
  • IKT N/A
  • EPS Growth
  • TUSK N/A
  • IKT N/A
  • EPS
  • TUSK N/A
  • IKT N/A
  • Revenue
  • TUSK $207,208,000.00
  • IKT N/A
  • Revenue This Year
  • TUSK N/A
  • IKT N/A
  • Revenue Next Year
  • TUSK $28.22
  • IKT N/A
  • P/E Ratio
  • TUSK N/A
  • IKT N/A
  • Revenue Growth
  • TUSK N/A
  • IKT N/A
  • 52 Week Low
  • TUSK $1.68
  • IKT $1.12
  • 52 Week High
  • TUSK $4.94
  • IKT $4.20
  • Technical
  • Relative Strength Index (RSI)
  • TUSK 54.21
  • IKT 35.29
  • Support Level
  • TUSK $2.83
  • IKT $1.62
  • Resistance Level
  • TUSK $3.12
  • IKT $1.78
  • Average True Range (ATR)
  • TUSK 0.14
  • IKT 0.12
  • MACD
  • TUSK -0.01
  • IKT -0.02
  • Stochastic Oscillator
  • TUSK 41.94
  • IKT 17.65

About TUSK Mammoth Energy Services Inc.

Mammoth Energy Services Inc is an integrated energy services company engaged in providing products and services to enable the exploration and development of North American onshore unconventional oil and natural gas reserves as well as the construction and repair of the electric grid for private utilities, public investor-owned utilities, and co-operative utilities through infrastructure services businesses. The company had three reportable segments, which includes well completion services (Well Completion), infrastructure services (Infrastructure) and natural sand proppant services (Sand). Key revenue is generated from Infrastructure which include electric utility infrastructure services to government-funded utilities, private utilities, public investor-owned utilities, etc.

About IKT Inhibikase Therapeutics Inc.

Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.

Share on Social Networks: